RNA Manufacturing Resources
-
5 Key Considerations For Companies Outsourcing Process Development
6/9/2025
Venture capital in biotech remains strong post-pandemic, especially in cell and gene therapies. Discover five key factors to help companies choose between in-house and outsourced process development strategies.
-
mRNA Vaccine Development: Planning, Workflow, Supply Chain Success
5/17/2022
A review of insights derived from the development of mRNA-based COVID-19 vaccines and how they can be applied to accelerate progress in the manufacture of vaccines and therapeutics moving forward.
-
CMC And Regulatory Considerations For CRISPR Therapies
3/21/2024
This article explores the details of Chemistry, Manufacturing, and Controls and Critical Quality Attributes, which play an important role in gene editing.
-
Understanding The Microfluidic Platforms For Scaling Nanoparticle Production
10/13/2022
Learn about the benefits of microfluidics for nanoparticle production over traditional methods as well as scaling nanoparticle production for clinical or industrial use.
-
mRNA Manufacturing With Fed-Batch In Vitro Transcription
2/13/2026
A milliliter-scale approach to IVT optimization reveals how controlled feeding, precise pH management, and real-time monitoring can boost mRNA yield and streamline scale-up to larger bioreactor volumes.
-
Improvement Of Self-Amplifying RNA Quality And Potency With IVT Optimization
2/4/2026
Explore our study on optimizing In-Vitro Transcription (IVT) conditions for self-amplifying RNAs to achieve high yields, low residual dsRNA, and improved potency, and learn how these advancements can enhance RNA-based therapies.
-
Solving Aseptic Filling Challenges For Your Advanced Therapeutics
8/20/2025
Explore aseptic filling workcells, modalities, agency approvals, and insights from six expert users that offer a peer-driven look at industry innovation and benchmarks.
-
CAR T Set The Pace So All Can Win The Cell Therapy Race
7/15/2024
Gain insight into the modest origins of cell therapy manufacturing and how this history has paved the way for future advancements from Bill Shingleton, R&D Leader at Cytiva.
-
Building Local Biomanufacturing Capacity In South Africa
2/11/2025
Biovac evolved from a vaccine supplier to a biopharmaceutical innovator, providing a blueprint for expanding Africa's vaccine manufacturing capacity. Gain valuable insights from their journey.
-
Strategize For Success With Single-Use Biomanufacturing Systems
10/29/2025
Single-use technologies are reshaping biomanufacturing workflows. Discover the key stages of implementation and how strategic choices drive success across the entire production process.